These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 577926)

  • 1. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography.
    Forrester JV; Sutherland GR; McDougall IR
    J Clin Endocrinol Metab; 1977 Aug; 45(2):221-4. PubMed ID: 577926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy.
    Willinsky RA; Arenson AM; Hurwitz JJ; Szalai J
    J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
    Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
    Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy].
    Murakami Y; Kanamoto T; Tsuboi T; Maeda T; Inoue Y
    Nippon Ganka Gakkai Zasshi; 2000 Jan; 104(1):34-8. PubMed ID: 10659624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE; Levin L
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy.
    Murakami Y; Kanamoto T; Tuboi T; Maeda T; Inoue Y
    Jpn J Ophthalmol; 2001; 45(6):622-7. PubMed ID: 11754905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact B-scan echographic diagnosis of ophthalmopathic Graves' disease.
    Hodes BL; Stern G
    J Clin Ultrasound; 1975 Dec; 3(4):255-61. PubMed ID: 829528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital lymphoma masquerading as thyroid ophthalmopathy.
    Boyce PJ
    J Am Optom Assoc; 1998 Oct; 69(10):666-73. PubMed ID: 9805448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysthyroid orbitopathy.
    Jacobson DM
    Semin Neurol; 2000; 20(1):43-54. PubMed ID: 10874776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graves' ophthalmopathy--a prospective clinical study].
    Bogdănici C; Marcu C
    Oftalmologia; 1999; 48(3):19-22, 25. PubMed ID: 10641113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraocular muscle size comparison using standardized A-scan echography and computerized tomography scan measurements.
    Holt JE; O'Connor PS; Douglas JP; Byrne B
    Ophthalmology; 1985 Oct; 92(10):1351-5. PubMed ID: 3906489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolated hypertrophy of the superior oblique muscle in Basedow disease].
    Charif Chefchaouni M; Bernoussi A; Hajji Z; Idrissi Noury H; Loughzail K; Chaoui Z; Berraho A
    Bull Soc Belge Ophtalmol; 2005; (295):11-5. PubMed ID: 15849983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of standardized ophthalmic echography in the management of Graves' ophthalmopathy.
    Ossoinig KC
    Dev Ophthalmol; 1989; 20():28-37. PubMed ID: 2687053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.